Clinical Trial Update: Improvement of Patients With Chronic Heart Failure Using NT-proBNP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing improvement in congestive heart failure patients using the NT-proBNP biomarker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Unity Health Toronto | Conditions: Congestive Heart Failure | Phase 4 | Status: UNKNOWN